VectorBuilder Redefines Plasmid Standards with miniVec
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
These products strengthen poultry immunity, improve productivity, and support sustainable farming practices~
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
This collaboration aims to combine Molcure’s cutting-edge AI technology with Boehringer Ingelheim’s extensive expertise in drug discovery
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
The new algorithm will be introduced as part of Roche’s CKD Algorithm Panelon thenavify Algorithm Suite
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
The NDA submission follows the successful completion of a pivotal Phase III global clinical trial
Subscribe To Our Newsletter & Stay Updated